AXITINIB

AXITINIB was reported 19550 times

AXITINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BODY SURFACE AREA DECREASED 12 0.1481
1 METASTATIC RENAL CELL CARCINOMA 210 0.1146
2 MALIGNANT URINARY TRACT NEOPLASM 12 0.1008
3 RENAL CELL CARCINOMA STAGE IV 8 0.0708
4 RENAL CANCER METASTATIC 46 0.0597
5 RENAL CELL CARCINOMA RECURRENT 7 0.0551
6 RENAL CELL CARCINOMA 245 0.0500
7 RENAL CANCER RECURRENT 7 0.0476
8 BODY SURFACE AREA INCREASED 6 0.0465
9 CLEAR CELL RENAL CELL CARCINOMA 27 0.0388
10 NEOPLASM PROGRESSION 1324 0.0380
11 IMMUNE-MEDIATED HEPATIC DISORDER 70 0.0359
12 CERVIX CARCINOMA RECURRENT 6 0.0337
13 AUTOIMMUNE MYOCARDITIS 7 0.0320
14 BLOOD CORTICOTROPHIN INCREASED 9 0.0311
15 NEPHRECTOMY 43 0.0289
16 PLANTAR ERYTHEMA 6 0.0243
17 IMMUNE-MEDIATED RENAL DISORDER 10 0.0242
18 DIVERTICULITIS INTESTINAL PERFORATED 8 0.0224
19 IMMUNE-MEDIATED NEPHRITIS 10 0.0213
20 IMMUNE-MEDIATED MYOCARDITIS 34 0.0210
21 IMMUNE-MEDIATED ARTHRITIS 8 0.0210
22 PRIMARY ADRENAL INSUFFICIENCY 6 0.0197
23 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 457 0.0196
24 DYSPHONIA 1013 0.0173
25 AUTOIMMUNE COLITIS 11 0.0171
26 IMMUNE-MEDIATED HYPOTHYROIDISM 19 0.0168
27 CANCER PAIN 39 0.0152
28 SECOND PRIMARY MALIGNANCY 125 0.0150
29 HAND-FOOT-AND-MOUTH DISEASE 12 0.0145
30 HEPATOBILIARY DISEASE 9 0.0144
31 HYPERKERATOSIS 79 0.0143
32 PRODUCT INEFFECTIVE 11 0.0140
33 ENCEPHALITIS AUTOIMMUNE 18 0.0137
34 APHONIA 186 0.0133
35 PROTEIN URINE 12 0.0133
36 THYROIDITIS 38 0.0126
37 IMMUNE-MEDIATED HEPATITIS 25 0.0122
38 ORAL PAIN 260 0.0116
39 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 10 0.0114
40 IMMUNE-MEDIATED ENCEPHALITIS 6 0.0113
41 METASTASES TO ADRENALS 10 0.0108
42 RENAL SURGERY 7 0.0107
43 THYROID HORMONES INCREASED 11 0.0105
44 DISEASE PROGRESSION 1213 0.0102
45 HYPOTHYROIDISM 318 0.0099
46 AUTOIMMUNE PANCREATITIS 5 0.0099
47 TUMOUR PAIN 13 0.0099
48 STOMATITIS 594 0.0098
49 POLYCYTHAEMIA 20 0.0097
50 NEPHRITIS 32 0.0096
51 PROTEINURIA 182 0.0096
52 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 91 0.0095
53 GLOSSITIS 33 0.0093
54 PNEUMOTHORAX SPONTANEOUS 6 0.0088
55 PROTEIN URINE PRESENT 44 0.0088
56 HYPOPITUITARISM 15 0.0086
57 TUMOUR PSEUDOPROGRESSION 9 0.0082
58 TONGUE DISCOMFORT 34 0.0080
59 ADRENAL INSUFFICIENCY 97 0.0080
60 CORTISOL DECREASED 9 0.0079
61 RENAL HAEMORRHAGE 16 0.0079
62 GENITAL RASH 11 0.0077
63 RENAL CANCER 359 0.0075
64 THYROID DISORDER 116 0.0075
65 ADRENAL DISORDER 14 0.0073
66 SECONDARY ADRENOCORTICAL INSUFFICIENCY 11 0.0073
67 TUMOUR HAEMORRHAGE 20 0.0070
68 MALIGNANT HYPERTENSION 6 0.0070
69 HYPOTHALAMO-PITUITARY DISORDER 10 0.0069
70 CAPILLARY LEAK SYNDROME 14 0.0068
71 NEPHROTIC SYNDROME 46 0.0067
72 ENTEROVESICAL FISTULA 5 0.0066
73 DIZZINESS EXERTIONAL 5 0.0066
74 IMMUNE-MEDIATED LUNG DISEASE 12 0.0066
75 GLOSSODYNIA 145 0.0065
76 BLOOD THYROID STIMULATING HORMONE INCREASED 59 0.0064
77 HYPERTENSION 1331 0.0063
78 CARDIAC DYSFUNCTION 23 0.0062
79 MYOCARDITIS 70 0.0061
80 PNEUMATOSIS INTESTINALIS 17 0.0060
81 MALIGNANT PLEURAL EFFUSION 10 0.0059
82 ENZYME LEVEL INCREASED 5 0.0059
83 IMMUNE-MEDIATED ADVERSE REACTION 9 0.0059
84 PRERENAL FAILURE 8 0.0057
85 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 7 0.0056
86 ORAL DISCOMFORT 78 0.0056
87 BLOOD PRESSURE INCREASED 855 0.0056
88 THYROID FUNCTION TEST ABNORMAL 23 0.0055
89 HYPOPHYSITIS 11 0.0055
90 TONGUE BLISTERING 12 0.0054
91 TYPE 1 DIABETES MELLITUS 32 0.0053
92 HOSPICE CARE 52 0.0053
93 BLISTER 286 0.0051
94 HYPERAESTHESIA 41 0.0050
95 HEPATOTOXICITY 111 0.0050
96 HEPATIC FUNCTION ABNORMAL 183 0.0049
97 DENTAL CARE 9 0.0049
98 NONINFECTIVE GINGIVITIS 7 0.0048
99 TASTE DISORDER 98 0.0048
100 GASTROINTESTINAL PERFORATION 20 0.0048
101 GASTROINTESTINAL TOXICITY 23 0.0048
102 MYOCARDIAL NECROSIS MARKER INCREASED 8 0.0048
103 HYPERAESTHESIA TEETH 6 0.0048
104 URINARY BLADDER HAEMORRHAGE 10 0.0047
105 HAEMORRHAGE URINARY TRACT 12 0.0047
106 DECREASED APPETITE 1094 0.0047
107 GALLBLADDER ENLARGEMENT 5 0.0046
108 BILIARY OBSTRUCTION 6 0.0046
109 IMMUNE-MEDIATED ENTEROCOLITIS 17 0.0046
110 HEPATITIS TOXIC 12 0.0046
111 BLOOD PRESSURE ABNORMAL 91 0.0046
112 GINGIVAL PAIN 36 0.0045
113 PROTEIN TOTAL INCREASED 12 0.0045
114 AUTOIMMUNE HEPATITIS 31 0.0045
115 NEOPLASM RECURRENCE 15 0.0044
116 HAEMOGLOBIN INCREASED 20 0.0044
117 RENAL MASS 9 0.0044
118 IMMUNE-MEDIATED MYOSITIS 12 0.0043
119 HYPERTHYROIDISM 63 0.0043
120 AORTIC DISSECTION 18 0.0043
121 MYOSITIS 39 0.0043
122 AMYLASE INCREASED 16 0.0043
123 PNEUMOPERITONEUM 8 0.0043
124 HEPATIC CYTOLYSIS 55 0.0043
125 MUCOSAL INFLAMMATION 111 0.0042
126 HYPOGEUSIA 8 0.0041
127 DIARRHOEA 2593 0.0040
128 FEEDING DISORDER 81 0.0040
129 RED BLOOD CELL COUNT INCREASED 11 0.0040
130 ORAL MUCOSAL ERUPTION 6 0.0039
131 METASTASES TO LUNG 45 0.0039
132 EATING DISORDER 82 0.0038
133 ESSENTIAL HYPERTENSION 7 0.0038
134 BLOOD THYROID STIMULATING HORMONE ABNORMAL 7 0.0038
135 MALIGNANT NEOPLASM PROGRESSION 385 0.0038
136 HYPERTRANSAMINASAEMIA 26 0.0037
137 BLOOD PRESSURE DIASTOLIC INCREASED 17 0.0037
138 RADIOTHERAPY 7 0.0037
139 ACUTE CORONARY SYNDROME 30 0.0036
140 CHOLECYSTITIS 43 0.0036
141 HEPATIC ENZYME ABNORMAL 18 0.0036
142 MYASTHENIA GRAVIS 29 0.0036
143 METASTASES TO SPINE 12 0.0036
144 VOCAL CORD DISORDER 7 0.0035
145 BRAIN OPERATION 8 0.0035
146 LEUKOENCEPHALOPATHY 13 0.0035
147 RETINAL VEIN OCCLUSION 10 0.0035
148 ENTEROCOLITIS 20 0.0035
149 RENAL IMPAIRMENT 291 0.0035
150 BLOOD CALCIUM INCREASED 30 0.0034
151 SKIN EROSION 11 0.0034
152 ORAL DISORDER 25 0.0034
153 LIVER FUNCTION TEST INCREASED 73 0.0034
154 PULMONARY INFARCTION 8 0.0034
155 VOCAL CORD PARALYSIS 6 0.0033
156 SUSPECTED OFF LABEL USE 15 0.0033
157 FAECES SOFT 24 0.0033
158 PNEUMOTHORAX 52 0.0033
159 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 5 0.0033
160 HEPATITIS 83 0.0032
161 SKIN TOXICITY 18 0.0032
162 PEMPHIGOID 24 0.0032
163 APPENDICITIS PERFORATED 8 0.0031
164 DEATH 2698 0.0031
165 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 5 0.0031
166 CEREBRAL INFARCTION 76 0.0031
167 SKIN LESION 85 0.0031
168 HAEMATOCRIT INCREASED 7 0.0031
169 CHOLANGITIS 19 0.0031
170 HYPERTENSIVE CRISIS 34 0.0031
171 TONGUE DISORDER 22 0.0030
172 ENCEPHALITIS 21 0.0030
173 TROPONIN INCREASED 23 0.0030
174 ANORECTAL DISORDER 6 0.0030
175 THERAPY CHANGE 29 0.0029
176 ENTERITIS INFECTIOUS 5 0.0029
177 INTRACARDIAC THROMBUS 9 0.0029
178 BRAIN OEDEMA 37 0.0029
179 PROTEIN TOTAL DECREASED 11 0.0029
180 WEIGHT ABNORMAL 7 0.0029
181 RADIUS FRACTURE 7 0.0029
182 RENAL CANCER STAGE IV 8 0.0029
183 CARDIOMYOPATHY 43 0.0029
184 HAEMOPTYSIS 81 0.0029
185 PRODUCT DOSE OMISSION IN ERROR 82 0.0029
186 DEHYDRATION 385 0.0029
187 WEIGHT DECREASED 805 0.0029
188 BLOOD POTASSIUM INCREASED 46 0.0028
189 POLYMYALGIA RHEUMATICA 9 0.0028
190 OSTEONECROSIS OF JAW 70 0.0028
191 AGEUSIA 70 0.0028
192 NEOPLASM MALIGNANT 186 0.0028
193 NEAR DEATH EXPERIENCE 9 0.0027
194 FATIGUE 2122 0.0027
195 DIVERTICULUM INTESTINAL HAEMORRHAGIC 6 0.0027
196 LIVER DISORDER 118 0.0027
197 COMPUTERISED TOMOGRAM ABNORMAL 6 0.0026
198 DRY MOUTH 214 0.0026
199 GINGIVAL RECESSION 5 0.0026
200 HYPERCALCAEMIA 32 0.0026
201 DRY THROAT 26 0.0026
202 RHINALGIA 7 0.0025
203 PROCTITIS 7 0.0025
204 BONE LESION 9 0.0025
205 PULSE ABNORMAL 6 0.0025
206 GINGIVAL SWELLING 11 0.0025
207 CORONARY ARTERY THROMBOSIS 5 0.0025
208 FUNGAL SKIN INFECTION 10 0.0025
209 LIP PAIN 7 0.0024
210 HYPOPHAGIA 62 0.0024
211 APPETITE DISORDER 16 0.0024
212 CARDIAC FAILURE ACUTE 16 0.0024
213 NASAL DRYNESS 15 0.0024
214 CONSTIPATION 522 0.0024
215 METASTASIS 17 0.0024
216 RENAL FUNCTION TEST ABNORMAL 11 0.0024
217 SKIN DISORDER 79 0.0024
218 TONGUE ULCERATION 8 0.0024
219 PATHOLOGICAL FRACTURE 12 0.0024
220 HEPATIC CYST 8 0.0024
221 BLOOD CHLORIDE DECREASED 6 0.0023
222 EXPOSED BONE IN JAW 5 0.0023
223 CHAPPED LIPS 10 0.0023
224 TRANSAMINASES INCREASED 51 0.0023
225 PULMONARY THROMBOSIS 25 0.0023
226 MASTICATION DISORDER 7 0.0023
227 BLOOD CREATININE INCREASED 149 0.0023
228 GAIT INABILITY 76 0.0023
229 INTERSTITIAL LUNG DISEASE 110 0.0023
230 BLOOD ALBUMIN DECREASED 18 0.0023
231 COLITIS 86 0.0023
232 PRODUCT PRESCRIBING ERROR 54 0.0023
233 ELECTROCARDIOGRAM T WAVE INVERSION 5 0.0023
234 EJECTION FRACTION DECREASED 35 0.0022
235 THERAPY PARTIAL RESPONDER 35 0.0022
236 INTESTINAL PERFORATION 25 0.0022
237 CHRONIC GASTRITIS 5 0.0022
238 PNEUMONITIS 60 0.0022
239 HICCUPS 18 0.0022
240 TUBULOINTERSTITIAL NEPHRITIS 41 0.0022
241 FOOD INTOLERANCE 8 0.0022
242 ODYNOPHAGIA 13 0.0022
243 EYELID DISORDER 5 0.0022
244 THERAPY CESSATION 111 0.0022
245 LIVER INJURY 53 0.0022
246 ANGIOPATHY 12 0.0021
247 CACHEXIA 11 0.0021
248 MOUTH ULCERATION 45 0.0021
249 IMPAIRED HEALING 70 0.0021
250 LISTLESS 7 0.0021
251 BLOOD SODIUM DECREASED 40 0.0021
252 BLOOD DISORDER 17 0.0021
253 HEPATIC ENZYME INCREASED 144 0.0021
254 TENDERNESS 22 0.0021
255 RETINAL HAEMORRHAGE 15 0.0021
256 ILEUS 26 0.0021
257 LIPASE INCREASED 16 0.0021
258 PHARYNGEAL DISORDER 6 0.0021
259 UPPER RESPIRATORY TRACT CONGESTION 6 0.0021
260 METASTASES TO BONE 34 0.0021
261 BONE CANCER 9 0.0021
262 BLOOD TEST ABNORMAL 29 0.0021
263 GASTROINTESTINAL NECROSIS 6 0.0021
264 SPINAL CORD COMPRESSION 8 0.0021
265 THERAPY INTERRUPTED 146 0.0020
266 GLOMERULONEPHRITIS 5 0.0020
267 ASTHENIA 765 0.0020
268 BLOOD CREATINE INCREASED 9 0.0020
269 HYPOACUSIS 87 0.0020
270 PLEURISY 12 0.0020
271 ORGANISING PNEUMONIA 10 0.0020
272 PULMONARY MASS 30 0.0020
273 BLOOD PRESSURE FLUCTUATION 48 0.0020
274 CENTRAL VENOUS CATHETERISATION 6 0.0020
275 RENAL PAIN 21 0.0020
276 GINGIVAL BLEEDING 27 0.0020
277 NECROSIS 11 0.0020
278 HAEMORRHAGE SUBCUTANEOUS 7 0.0020
279 ABDOMINAL INFECTION 5 0.0020
280 RENAL DISORDER 91 0.0020
281 CEREBRAL ISCHAEMIA 10 0.0019
282 CHOLECYSTITIS ACUTE 11 0.0019
283 HYPERBILIRUBINAEMIA 20 0.0019
284 EPISTAXIS 143 0.0019
285 BLOOD URINE PRESENT 36 0.0019
286 SKIN ULCER 49 0.0019
287 CANDIDA INFECTION 32 0.0019
288 SUDDEN DEATH 20 0.0019
289 SPEECH DISORDER 99 0.0019
290 BLOOD BILIRUBIN INCREASED 51 0.0019
291 METASTASES TO CENTRAL NERVOUS SYSTEM 24 0.0019
292 GUILLAIN-BARRE SYNDROME 9 0.0019
293 GINGIVITIS 10 0.0019
294 DRUG-INDUCED LIVER INJURY 58 0.0018
295 EAR CONGESTION 5 0.0018
296 GASTRIC PERFORATION 5 0.0018
297 BOWEL MOVEMENT IRREGULARITY 14 0.0018
298 ASPARTATE AMINOTRANSFERASE INCREASED 97 0.0018
299 HYPERAMMONAEMIA 9 0.0018
300 CEREBRAL HAEMATOMA 6 0.0018
301 NAIL DISCOLOURATION 7 0.0018
302 EAR DISCOMFORT 18 0.0018
303 WOUND COMPLICATION 6 0.0017
304 EAR DISORDER 8 0.0017
305 NEOPLASM 20 0.0017
306 ALANINE AMINOTRANSFERASE INCREASED 106 0.0017
307 BILIARY COLIC 5 0.0017
308 PROCTALGIA 11 0.0017
309 HYPERTRIGLYCERIDAEMIA 10 0.0017
310 FLANK PAIN 16 0.0017
311 SKIN EXFOLIATION 143 0.0017
312 DRUG ERUPTION 30 0.0017
313 NEPHROPATHY TOXIC 19 0.0017
314 SKIN FISSURES 33 0.0017
315 HAEMORRHAGIC DIATHESIS 6 0.0017
316 HYPERSOMNIA 48 0.0017
317 OROPHARYNGEAL PAIN 155 0.0017
318 CORONAVIRUS INFECTION 11 0.0017
319 CHEILITIS 9 0.0017
320 DRY SKIN 220 0.0016
321 BLOOD LACTATE DEHYDROGENASE INCREASED 26 0.0016
322 BLOOD PRESSURE SYSTOLIC INCREASED 32 0.0016
323 HAEMORRHOIDAL HAEMORRHAGE 8 0.0016
324 DYSCHEZIA 5 0.0016
325 GASTROINTESTINAL PAIN 18 0.0016
326 ELECTROLYTE IMBALANCE 19 0.0016
327 HAEMATURIA 56 0.0016
328 INTESTINAL ISCHAEMIA 9 0.0016
329 DISSEMINATED INTRAVASCULAR COAGULATION 23 0.0016
330 PLEURAL EFFUSION 99 0.0016
331 BLOOD MAGNESIUM DECREASED 14 0.0016
332 HEPATIC LESION 7 0.0016
333 MUSCULOSKELETAL CHEST PAIN 25 0.0016
334 HAIR COLOUR CHANGES 20 0.0016
335 ACUTE PULMONARY OEDEMA 9 0.0016
336 TUMOUR LYSIS SYNDROME 14 0.0016
337 GENERAL PHYSICAL HEALTH DETERIORATION 184 0.0016
338 DYSPHAGIA 150 0.0016
339 HAEMATEMESIS 40 0.0016
340 CARDIOTOXICITY 14 0.0016
341 GASTRIC INFECTION 6 0.0016
342 ENTERITIS 10 0.0016
343 PAIN IN EXTREMITY 459 0.0016
344 STRESS CARDIOMYOPATHY 9 0.0015
345 BLOOD THYROID STIMULATING HORMONE DECREASED 7 0.0015
346 HYPOVOLAEMIA 9 0.0015
347 HAEMORRHAGIC STROKE 12 0.0015
348 EPIGASTRIC DISCOMFORT 6 0.0015
349 WEIGHT FLUCTUATION 16 0.0015
350 ALTERED STATE OF CONSCIOUSNESS 33 0.0015
351 DYSGEUSIA 113 0.0015
352 POLYARTHRITIS 8 0.0015
353 CHRONIC MYELOID LEUKAEMIA 7 0.0015
354 NASAL DISCOMFORT 12 0.0015
355 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 5 0.0015
356 CEREBRAL ATROPHY 6 0.0015
357 ATRIAL FLUTTER 12 0.0015
358 PERFORMANCE STATUS DECREASED 7 0.0015
359 CREATININE RENAL CLEARANCE DECREASED 6 0.0015
360 YELLOW SKIN 7 0.0015
361 INTRACRANIAL ANEURYSM 6 0.0015
362 CEREBRAL DISORDER 11 0.0015
363 NAIL DISORDER 13 0.0015
364 METASTASES TO LIVER 26 0.0015
365 PULMONARY OEDEMA 66 0.0015
366 BONE PAIN 86 0.0015
367 BRAIN FOG 23 0.0015
368 ASCITES 43 0.0015
369 FAECALOMA 8 0.0015
370 HYPERURICAEMIA 6 0.0015
371 ILLNESS 150 0.0015
372 TEMPERATURE INTOLERANCE 15 0.0015
373 HUMERUS FRACTURE 7 0.0015
374 NAUSEA 1145 0.0014
375 CARDIAC FAILURE 116 0.0014
376 PANCREATITIS 76 0.0014
377 HAEMORRHOIDS 28 0.0014
378 FULL BLOOD COUNT ABNORMAL 15 0.0014
379 PNEUMONIA BACTERIAL 13 0.0014
380 INFLAMMATORY MARKER INCREASED 7 0.0014
381 SCAB 16 0.0014
382 GALLBLADDER DISORDER 25 0.0014
383 HYPERKALAEMIA 49 0.0014
384 GOUT 25 0.0014
385 CORONARY ARTERY STENOSIS 7 0.0014
386 SKIN ATROPHY 8 0.0014
387 EXERCISE TOLERANCE DECREASED 8 0.0014
388 BLOOD URIC ACID INCREASED 8 0.0014
389 MONOPLEGIA 6 0.0014
390 THROMBOSIS 111 0.0014
391 OFF LABEL USE 1207 0.0014
392 DYSLIPIDAEMIA 7 0.0014
393 FRACTURE 26 0.0014
394 GENERALISED OEDEMA 17 0.0014
395 MOUTH HAEMORRHAGE 10 0.0014
396 INCREASED UPPER AIRWAY SECRETION 7 0.0014
397 PNEUMONIA ASPIRATION 34 0.0014
398 ARTERIOSCLEROSIS CORONARY ARTERY 9 0.0014
399 ENCEPHALOPATHY 33 0.0013
400 QUALITY OF LIFE DECREASED 18 0.0013
401 CEREBRAL HAEMORRHAGE 48 0.0013
402 BLOOD CALCIUM DECREASED 15 0.0013
403 AUTOIMMUNE DISORDER 13 0.0013
404 BLOOD PRESSURE INADEQUATELY CONTROLLED 8 0.0013
405 OROPHARYNGEAL DISCOMFORT 12 0.0013
406 CONFUSIONAL STATE 213 0.0013
407 BLOOD UREA INCREASED 22 0.0013
408 ACUTE KIDNEY INJURY 201 0.0013
409 ABDOMINAL DISCOMFORT 220 0.0013
410 IMMUNE THROMBOCYTOPENIA 6 0.0013
411 CLAVICLE FRACTURE 5 0.0013
412 GINGIVAL DISORDER 5 0.0013
413 HEMIPARESIS 22 0.0013
414 PERICARDIAL EFFUSION 30 0.0013
415 PNEUMOCYSTIS JIROVECII PNEUMONIA 13 0.0013
416 HIP SURGERY 7 0.0013
417 APHTHOUS ULCER 10 0.0013
418 ISCHAEMIC STROKE 23 0.0013
419 ACUTE MYOCARDIAL INFARCTION 38 0.0013
420 PELVIC FRACTURE 10 0.0013
421 PULMONARY HAEMORRHAGE 10 0.0013
422 DUODENAL ULCER 9 0.0013
423 PULMONARY TOXICITY 9 0.0013
424 LIVER FUNCTION TEST ABNORMAL 37 0.0013
425 MULTIPLE ORGAN DYSFUNCTION SYNDROME 36 0.0013
426 THERMAL BURN 9 0.0013
427 FURUNCLE 10 0.0013
428 LIMB DISCOMFORT 39 0.0013
429 ULCER 20 0.0013
430 GROIN PAIN 11 0.0013
431 APHAGIA 6 0.0012
432 PANCREATITIS ACUTE 28 0.0012
433 FRUSTRATION TOLERANCE DECREASED 10 0.0012
434 DIZZINESS POSTURAL 12 0.0012
435 BLOOD POTASSIUM DECREASED 37 0.0012
436 VOMITING 578 0.0012
437 GAIT DISTURBANCE 235 0.0012
438 INTERNAL HAEMORRHAGE 14 0.0012
439 GLOMERULAR FILTRATION RATE DECREASED 15 0.0012
440 MALAISE 535 0.0012
441 PANCREATIC DISORDER 6 0.0012
442 SPINAL OPERATION 15 0.0012
443 TOOTHACHE 22 0.0012
444 MYALGIA 206 0.0012
445 BLOOD ALKALINE PHOSPHATASE INCREASED 30 0.0012
446 TOOTH EXTRACTION 15 0.0012
447 MENINGITIS 8 0.0012
448 RETINAL DETACHMENT 11 0.0012
449 SPINAL PAIN 14 0.0012
450 SEIZURE 138 0.0012
451 PAROSMIA 9 0.0012
452 DIVERTICULITIS 33 0.0012
453 OESOPHAGITIS 13 0.0012
454 HERNIA 23 0.0012
455 SWOLLEN TONGUE 37 0.0012
456 ABDOMINAL PAIN UPPER 243 0.0012
457 GENERAL PHYSICAL CONDITION ABNORMAL 8 0.0012
458 POLYNEUROPATHY 14 0.0012
459 HYPOCALCAEMIA 22 0.0012
460 MALNUTRITION 13 0.0012
461 OSTEOMYELITIS 21 0.0012
462 GASTRIC ULCER 22 0.0012
463 HYPOALBUMINAEMIA 9 0.0012
464 PYELONEPHRITIS 10 0.0012
465 HYPONATRAEMIA 65 0.0012
466 HYPERGLYCAEMIA 42 0.0012
467 INGUINAL HERNIA 7 0.0011
468 WOUND 32 0.0011
469 GASTRITIS 30 0.0011
470 SINUS BRADYCARDIA 11 0.0011
471 PIGMENTATION DISORDER 7 0.0011
472 DYSSTASIA 33 0.0011
473 ANORECTAL DISCOMFORT 6 0.0011
474 ANAL FISTULA 6 0.0011
475 TOOTH DISORDER 25 0.0011
476 RASH 488 0.0011
477 DEMENTIA 31 0.0011
478 RENAL FAILURE 147 0.0011
479 DERMATITIS BULLOUS 8 0.0011
480 MUSCLE ATROPHY 14 0.0011
481 DECUBITUS ULCER 9 0.0011
482 ASPHYXIA 9 0.0011
483 C-REACTIVE PROTEIN INCREASED 40 0.0011
484 DYSPEPSIA 108 0.0011
485 APHASIA 33 0.0011
486 CARDIAC DISORDER 102 0.0011
487 INTENTIONAL DOSE OMISSION 31 0.0011
488 INCREASED TENDENCY TO BRUISE 10 0.0011
489 PRODUCT DOSE OMISSION ISSUE 319 0.0011
490 SENSITIVE SKIN 8 0.0011
491 NEUROPATHY PERIPHERAL 103 0.0011
492 HEMIPLEGIA 9 0.0011
493 INCOHERENT 7 0.0011
494 ARTHRITIS INFECTIVE 5 0.0011
495 ARTHRALGIA 448 0.0011
496 DRUG INTOLERANCE 104 0.0011
497 FLATULENCE 61 0.0011
498 COUGH 301 0.0011
499 NOCTURIA 13 0.0011
500 APPENDICITIS 10 0.0011
501 ARTERIOSCLEROSIS 10 0.0011
502 WALKING AID USER 7 0.0011
503 LUNG DISORDER 52 0.0011
504 HEPATOCELLULAR INJURY 15 0.0011
505 ABDOMINAL PAIN 246 0.0011
506 FACIAL PARALYSIS 9 0.0011
507 COLITIS MICROSCOPIC 5 0.0011
508 HYPOGLYCAEMIA 51 0.0011
509 CHOLECYSTECTOMY 12 0.0010
510 LABORATORY TEST ABNORMAL 31 0.0010
511 BACK PAIN 244 0.0010
512 DIABETES MELLITUS 80 0.0010
513 SKIN MASS 7 0.0010
514 ANURIA 9 0.0010
515 LEFT VENTRICULAR DYSFUNCTION 7 0.0010
516 MOUTH SWELLING 6 0.0010
517 METASTASES TO LYMPH NODES 7 0.0010
518 POSTOPERATIVE WOUND INFECTION 7 0.0010
519 HEPATIC FAILURE 31 0.0010
520 GASTROINTESTINAL DISORDER 92 0.0010
521 CEREBROVASCULAR ACCIDENT 173 0.0010
522 GASTRIC DISORDER 35 0.0010
523 DECREASED IMMUNE RESPONSIVENESS 10 0.0010
524 HAEMORRHAGE 106 0.0010
525 ATAXIA 12 0.0010
526 LARGE INTESTINE PERFORATION 7 0.0010
527 ABDOMINAL TENDERNESS 5 0.0010
528 JAUNDICE 27 0.0010
529 DERMATITIS 21 0.0010
530 FLUID INTAKE REDUCED 5 0.0010
531 JOINT STIFFNESS 26 0.0010
532 CHOLESTASIS 19 0.0010
533 LYMPHADENOPATHY 35 0.0010
534 DISORIENTATION 39 0.0010
535 EYELID PTOSIS 10 0.0010
536 MOTOR DYSFUNCTION 10 0.0010
537 TRANSIENT ISCHAEMIC ATTACK 33 0.0010
538 NEUTROPHIL COUNT INCREASED 10 0.0010
539 ABNORMAL FAECES 8 0.0010
540 MEMORY IMPAIRMENT 134 0.0010
541 LOCAL SWELLING 17 0.0010
542 DEVICE RELATED INFECTION 15 0.0010
543 REBOUND EFFECT 11 0.0010
544 EOSINOPHILIA 17 0.0010
545 VISUAL FIELD DEFECT 7 0.0010
546 PULMONARY EMBOLISM 92 0.0010
547 MUSCULAR WEAKNESS 110 0.0010
548 COGNITIVE DISORDER 45 0.0010
549 FAILURE TO THRIVE 5 0.0010
550 HEADACHE 603 0.0010
551 ATRIAL FIBRILLATION 93 0.0010
552 PERIPHERAL SWELLING 147 0.0010
553 LOCALISED INFECTION 23 0.0010
554 BALANCE DISORDER 82 0.0009
555 SCRATCH 10 0.0009
556 GAMMA-GLUTAMYLTRANSFERASE INCREASED 21 0.0009
557 CLOSTRIDIUM DIFFICILE COLITIS 10 0.0009
558 RASH PRURITIC 51 0.0009
559 ABSCESS 15 0.0009
560 HYDRONEPHROSIS 7 0.0009
561 DYSPNOEA EXERTIONAL 35 0.0009
562 ANAL ABSCESS 5 0.0009
563 MYOPATHY 8 0.0009
564 HAEMOGLOBIN DECREASED 95 0.0009
565 HEPATITIS ACUTE 6 0.0009
566 FAECES DISCOLOURED 20 0.0009
567 AORTIC ANEURYSM 7 0.0009
568 DIALYSIS 13 0.0009
569 DYSPNOEA 518 0.0009
570 ORAL CANDIDIASIS 12 0.0009
571 BACTERIAL INFECTION 17 0.0009
572 BLOOD TRIGLYCERIDES INCREASED 16 0.0009
573 RHINORRHOEA 58 0.0009
574 CYTOKINE RELEASE SYNDROME 18 0.0009
575 ATRIOVENTRICULAR BLOCK COMPLETE 6 0.0009
576 GASTROINTESTINAL INFLAMMATION 7 0.0009
577 PERICARDITIS 15 0.0009
578 TORSADE DE POINTES 7 0.0009
579 ARTHRITIS 70 0.0009
580 SUBARACHNOID HAEMORRHAGE 9 0.0009
581 EPILEPSY 27 0.0009
582 SLUGGISHNESS 9 0.0009
583 PLATELET COUNT DECREASED 94 0.0009
584 INFARCTION 6 0.0009
585 AMNESIA 57 0.0009
586 CENTRAL NERVOUS SYSTEM LESION 12 0.0009
587 MOVEMENT DISORDER 28 0.0009
588 ONYCHOCLASIS 6 0.0009
589 SKIN DISCOLOURATION 40 0.0009
590 BURNING SENSATION 61 0.0009
591 LETHARGY 50 0.0009
592 NERVE COMPRESSION 8 0.0009
593 IRON DEFICIENCY ANAEMIA 8 0.0009
594 HYPOAESTHESIA ORAL 13 0.0009
595 FEELING COLD 24 0.0009
596 PERSONALITY CHANGE 8 0.0009
597 BACK DISORDER 14 0.0009
598 URINARY TRACT INFECTION 146 0.0009
599 POLYURIA 7 0.0009
600 PAIN 524 0.0009
601 PAPULE 6 0.0009
602 HAEMATOCHEZIA 47 0.0009
603 SQUAMOUS CELL CARCINOMA 8 0.0008
604 PNEUMONIA 275 0.0008
605 BRADYKINESIA 5 0.0008
606 THROAT IRRITATION 38 0.0008
607 CHROMATURIA 19 0.0008
608 BODY HEIGHT DECREASED 9 0.0008
609 CARDIO-RESPIRATORY ARREST 35 0.0008
610 HYPERLIPIDAEMIA 10 0.0008
611 IMMUNE SYSTEM DISORDER 11 0.0008
612 NERVOUS SYSTEM DISORDER 26 0.0008
613 ACUTE RESPIRATORY FAILURE 16 0.0008
614 SOMNOLENCE 167 0.0008
615 BLOOD PRESSURE DECREASED 55 0.0008
616 RIB FRACTURE 17 0.0008
617 CHEST PAIN 153 0.0008
618 FLUID RETENTION 42 0.0008
619 CLOSTRIDIUM DIFFICILE INFECTION 18 0.0008
620 ARRHYTHMIA 39 0.0008
621 BONE DISORDER 15 0.0008
622 DERMATITIS ACNEIFORM 5 0.0008
623 BLOOD GLUCOSE FLUCTUATION 9 0.0008
624 MELAENA 18 0.0008
625 PSYCHIATRIC SYMPTOM 6 0.0008
626 LOWER GASTROINTESTINAL HAEMORRHAGE 6 0.0008
627 HAEMATOMA 21 0.0008
628 ABASIA 20 0.0008
629 COVID-19 142 0.0008
630 LIGAMENT SPRAIN 8 0.0008
631 NIGHT SWEATS 26 0.0008
632 SKIN INFECTION 9 0.0008
633 CORONARY ARTERY OCCLUSION 11 0.0008
634 MITRAL VALVE INCOMPETENCE 9 0.0008
635 DEPRESSED MOOD 42 0.0008
636 HYPOTENSION 159 0.0008
637 MENTAL STATUS CHANGES 22 0.0008
638 POLLAKIURIA 33 0.0008
639 HYPOTHERMIA 8 0.0008
640 MENTAL IMPAIRMENT 19 0.0008
641 ANAEMIA 149 0.0008
642 GASTROINTESTINAL INFECTION 7 0.0008
643 PRURITUS 300 0.0008
644 RENAL FAILURE CHRONIC 6 0.0008
645 PAIN OF SKIN 21 0.0008
646 FREQUENT BOWEL MOVEMENTS 21 0.0008
647 HAEMOGLOBIN ABNORMAL 5 0.0008
648 SEPSIS 86 0.0008
649 COVID-19 PNEUMONIA 9 0.0008
650 BRAIN NEOPLASM 7 0.0008
651 BLINDNESS 31 0.0008
652 DYSURIA 28 0.0008
653 DYSGRAPHIA 5 0.0008
654 PRODUCTIVE COUGH 36 0.0008
655 ERYTHEMA MULTIFORME 7 0.0007
656 HEPATIC ENCEPHALOPATHY 7 0.0007
657 DIARRHOEA HAEMORRHAGIC 7 0.0007
658 STENT PLACEMENT 6 0.0007
659 MYOCARDIAL INFARCTION 129 0.0007
660 INFECTION 107 0.0007
661 COMA 35 0.0007
662 FEELING ABNORMAL 176 0.0007
663 CELLULITIS 37 0.0007
664 DIPLOPIA 19 0.0007
665 PYREXIA 253 0.0007
666 TENDON RUPTURE 9 0.0007
667 THIRST 13 0.0007
668 DEAFNESS 19 0.0007
669 MUSCULOSKELETAL PAIN 38 0.0007
670 CYST 9 0.0007
671 ATELECTASIS 7 0.0007
672 PERITONITIS 15 0.0007
673 VENTRICULAR FIBRILLATION 8 0.0007
674 INTESTINAL OBSTRUCTION 27 0.0007
675 PHARYNGEAL SWELLING 7 0.0007
676 VITREOUS FLOATERS 7 0.0007
677 HEART RATE DECREASED 25 0.0007
678 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 34 0.0007
679 RESPIRATORY DISORDER 21 0.0007
680 CHOLELITHIASIS 23 0.0007
681 SPINAL FRACTURE 14 0.0007
682 PARALYSIS 10 0.0007
683 THINKING ABNORMAL 13 0.0007
684 CARDIOGENIC SHOCK 10 0.0007
685 PLATELET COUNT INCREASED 9 0.0007
686 BONE MARROW FAILURE 14 0.0007
687 TOOTH ABSCESS 7 0.0007
688 RASH MACULAR 24 0.0007
689 GASTROENTERITIS 10 0.0007
690 MUSCULOSKELETAL DISORDER 13 0.0007
691 LOWER RESPIRATORY TRACT INFECTION 31 0.0007
692 INFUSION RELATED REACTION 45 0.0007
693 PURPURA 6 0.0007
694 HOSPITALISATION 104 0.0007
695 DIZZINESS 336 0.0007
696 JOINT RANGE OF MOTION DECREASED 9 0.0007
697 THROMBOCYTOPENIA 75 0.0007
698 DRUG LEVEL INCREASED 11 0.0007
699 NECK PAIN 37 0.0007
700 URINARY RETENTION 22 0.0007
701 RETCHING 14 0.0007
702 BREAST PAIN 7 0.0007
703 FALL 218 0.0007
704 RECTAL HAEMORRHAGE 28 0.0007
705 HYPOKALAEMIA 30 0.0006
706 SMALL INTESTINAL OBSTRUCTION 8 0.0006
707 HUNGER 9 0.0006
708 CIRCULATORY COLLAPSE 11 0.0006
709 BRONCHOPULMONARY ASPERGILLOSIS 5 0.0006
710 RESPIRATORY FAILURE 47 0.0006
711 MASS 9 0.0006
712 PRODUCT DISPENSING ERROR 14 0.0006
713 INSOMNIA 171 0.0006
714 SKIN REACTION 9 0.0006
715 SECRETION DISCHARGE 8 0.0006
716 EYE DISORDER 21 0.0006
717 PRODUCT USE IN UNAPPROVED INDICATION 158 0.0006
718 GASTROOESOPHAGEAL REFLUX DISEASE 51 0.0006
719 CARDIOVASCULAR DISORDER 16 0.0006
720 FUNGAL INFECTION 21 0.0006
721 ANGINA PECTORIS 18 0.0006
722 OEDEMA 34 0.0006
723 MOBILITY DECREASED 45 0.0006
724 LOWER LIMB FRACTURE 12 0.0006
725 THERAPEUTIC RESPONSE UNEXPECTED 28 0.0006
726 PARAESTHESIA ORAL 9 0.0006
727 CHILLS 73 0.0006
728 HYPOKINESIA 9 0.0006
729 EYE INFECTION 7 0.0006
730 STATUS EPILEPTICUS 7 0.0006
731 NEURALGIA 15 0.0006
732 IMPAIRED DRIVING ABILITY 7 0.0006
733 MUSCLE SPASMS 113 0.0006
734 OEDEMA PERIPHERAL 75 0.0006
735 NODULE 8 0.0006
736 MICTURITION URGENCY 7 0.0006
737 MYELOSUPPRESSION 22 0.0006
738 GASTROINTESTINAL HAEMORRHAGE 51 0.0006
739 SWELLING 57 0.0006
740 SKIN HAEMORRHAGE 9 0.0006
741 TOOTH INFECTION 8 0.0006
742 HAEMATOCRIT DECREASED 12 0.0006
743 POOR QUALITY SLEEP 13 0.0006
744 POST PROCEDURAL HAEMORRHAGE 7 0.0006
745 HEAD INJURY 19 0.0006
746 SALIVARY HYPERSECRETION 6 0.0006
747 EYE HAEMORRHAGE 8 0.0006
748 WHITE BLOOD CELL COUNT INCREASED 23 0.0006
749 BRAIN INJURY 6 0.0006
750 SEPTIC SHOCK 26 0.0006
751 BLOOD GLUCOSE ABNORMAL 11 0.0006
752 EMPHYSEMA 6 0.0006
753 ABDOMINAL DISTENSION 62 0.0006
754 ABDOMINAL PAIN LOWER 15 0.0006
755 HIP FRACTURE 19 0.0006
756 HEPATIC STEATOSIS 11 0.0006
757 VISUAL IMPAIRMENT 73 0.0006
758 LIMB INJURY 16 0.0006
759 FEMUR FRACTURE 18 0.0006
760 MUSCULOSKELETAL DISCOMFORT 10 0.0006
761 STAPHYLOCOCCAL INFECTION 19 0.0006
762 INCREASED APPETITE 11 0.0006
763 DISTURBANCE IN ATTENTION 31 0.0006
764 PRODUCT USE ISSUE 108 0.0006
765 CONTUSION 55 0.0006
766 NEUROTOXICITY 10 0.0006
767 SYNCOPE 57 0.0006
768 BRADYCARDIA 30 0.0006
769 SCIATICA 9 0.0006
770 CHOKING 11 0.0006
771 INFLAMMATION 29 0.0006
772 KIDNEY INFECTION 11 0.0006
773 CARDIAC FAILURE CONGESTIVE 45 0.0006
774 FACIAL PAIN 5 0.0006
775 INTENTIONAL PRODUCT MISUSE 49 0.0006
776 RED BLOOD CELL COUNT DECREASED 16 0.0006
777 HAEMARTHROSIS 5 0.0006
778 DERMATITIS ALLERGIC 7 0.0006
779 HYPOAESTHESIA 83 0.0006
780 CATARACT 33 0.0006
781 LOSS OF CONSCIOUSNESS 71 0.0006
782 DEEP VEIN THROMBOSIS 36 0.0006
783 SKIN LACERATION 6 0.0006
784 PRODUCT PRESCRIBING ISSUE 12 0.0006
785 WOUND INFECTION 6 0.0005
786 DELIRIUM 19 0.0005
787 HEART RATE INCREASED 54 0.0005
788 RESPIRATORY DISTRESS 15 0.0005
789 DIABETIC KETOACIDOSIS 13 0.0005
790 URINARY INCONTINENCE 16 0.0005
791 ERYTHEMA 111 0.0005
792 RASH PAPULAR 12 0.0005
793 FISTULA 6 0.0005
794 ANGER 18 0.0005
795 VISION BLURRED 73 0.0005
796 DYSARTHRIA 20 0.0005
797 BLOOD COUNT ABNORMAL 8 0.0005
798 ROAD TRAFFIC ACCIDENT 22 0.0005
799 BLOOD CREATINE PHOSPHOKINASE INCREASED 15 0.0005
800 BLOOD GLUCOSE DECREASED 25 0.0005
801 ERUCTATION 10 0.0005
802 OXYGEN SATURATION DECREASED 29 0.0005
803 ACUTE HEPATIC FAILURE 7 0.0005
804 SURGERY 30 0.0005
805 LUNG NEOPLASM MALIGNANT 21 0.0005
806 PERIPHERAL COLDNESS 7 0.0005
807 LYMPHOCYTE COUNT DECREASED 9 0.0005
808 ACUTE RESPIRATORY DISTRESS SYNDROME 9 0.0005
809 PARAESTHESIA 80 0.0005
810 HEAD DISCOMFORT 9 0.0005
811 BLOOD IRON DECREASED 6 0.0005
812 RENAL INJURY 15 0.0005
813 HYPOMAGNESAEMIA 7 0.0005
814 ACCIDENT 6 0.0005
815 MUSCULOSKELETAL STIFFNESS 44 0.0005
816 UPPER LIMB FRACTURE 10 0.0005
817 SEASONAL ALLERGY 7 0.0005
818 PHARYNGITIS 6 0.0005
819 GENERALISED TONIC-CLONIC SEIZURE 8 0.0005
820 HYPOXIA 17 0.0005
821 TOXICITY TO VARIOUS AGENTS 81 0.0005
822 SKIN IRRITATION 22 0.0005
823 DISCOMFORT 29 0.0005
824 DRUG INTERACTION 75 0.0005
825 CONVULSION 27 0.0005
826 RENAL FAILURE ACUTE 20 0.0005
827 CYSTITIS 15 0.0005
828 COLON CANCER 7 0.0005
829 METABOLIC ACIDOSIS 15 0.0005
830 SLEEP DISORDER 33 0.0005
831 NEUTROPHIL COUNT DECREASED 19 0.0005
832 UNRESPONSIVE TO STIMULI 12 0.0005
833 BACK INJURY 5 0.0005
834 SARS-COV-2 TEST POSITIVE 6 0.0005
835 CONDITION AGGRAVATED 138 0.0005
836 ANKLE FRACTURE 7 0.0005
837 LUNG INFECTION 7 0.0005
838 FULL BLOOD COUNT DECREASED 9 0.0004
839 SNEEZING 10 0.0004
840 THROAT TIGHTNESS 12 0.0004
841 BODY TEMPERATURE INCREASED 9 0.0004
842 HALLUCINATION 33 0.0004
843 GASTRIC HAEMORRHAGE 5 0.0004
844 ADVERSE EVENT 40 0.0004
845 ALOPECIA 85 0.0004
846 CORONARY ARTERY DISEASE 13 0.0004
847 PHOTOSENSITIVITY REACTION 7 0.0004
848 NASOPHARYNGITIS 78 0.0004
849 FOOT FRACTURE 8 0.0004
850 COAGULOPATHY 7 0.0004
851 BLOOD GLUCOSE INCREASED 79 0.0004
852 HERPES ZOSTER 24 0.0004
853 PULMONARY FIBROSIS 8 0.0004
854 POST PROCEDURAL COMPLICATION 8 0.0004
855 UPPER GASTROINTESTINAL HAEMORRHAGE 7 0.0004
856 GLAUCOMA 8 0.0004
857 FACE OEDEMA 7 0.0004
858 ANOSMIA 6 0.0004
859 MENTAL DISORDER 18 0.0004
860 PRESCRIBED OVERDOSE 8 0.0004
861 INTENTIONAL PRODUCT USE ISSUE 36 0.0004
862 VERTIGO 25 0.0004
863 NASAL CONGESTION 24 0.0004
864 RHABDOMYOLYSIS 17 0.0004
865 BLOOD CHOLESTEROL INCREASED 19 0.0004
866 ORTHOSTATIC HYPOTENSION 7 0.0004
867 HAEMORRHAGE INTRACRANIAL 6 0.0004
868 ADVERSE DRUG REACTION 36 0.0004
869 HIP ARTHROPLASTY 6 0.0004
870 VIRAL INFECTION 13 0.0004
871 PHARYNGEAL OEDEMA 6 0.0004
872 JOINT SWELLING 47 0.0004
873 PAIN IN JAW 11 0.0004
874 GASTROENTERITIS VIRAL 7 0.0004
875 LEUKOCYTOSIS 7 0.0004
876 INTERNATIONAL NORMALISED RATIO INCREASED 11 0.0004
877 ACNE 29 0.0004
878 CHEST DISCOMFORT 39 0.0004
879 DEPRESSED LEVEL OF CONSCIOUSNESS 15 0.0004
880 WHITE BLOOD CELL COUNT DECREASED 41 0.0004
881 RASH ERYTHEMATOUS 18 0.0004
882 PHOTOPHOBIA 7 0.0004
883 MUSCLE TIGHTNESS 6 0.0004
884 PRESYNCOPE 9 0.0004
885 INFLUENZA 41 0.0004
886 CARDIAC ARREST 30 0.0004
887 VISUAL ACUITY REDUCED 12 0.0004
888 ARTHROPATHY 20 0.0004
889 HEART RATE IRREGULAR 8 0.0004
890 ERECTILE DYSFUNCTION 9 0.0004
891 HYPERSENSITIVITY 65 0.0003
892 RESPIRATORY TRACT INFECTION 9 0.0003
893 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 18 0.0003
894 APATHY 5 0.0003
895 COLD SWEAT 6 0.0003
896 ELECTROCARDIOGRAM QT PROLONGED 12 0.0003
897 KNEE ARTHROPLASTY 7 0.0003
898 HALLUCINATION, VISUAL 7 0.0003
899 LACRIMATION INCREASED 10 0.0003
900 PALLOR 9 0.0003
901 MOOD ALTERED 9 0.0003
902 ILL-DEFINED DISORDER 20 0.0003
903 RESTLESSNESS 12 0.0003
904 JOINT INJURY 7 0.0003
905 RESPIRATORY ARREST 9 0.0003
906 TINNITUS 15 0.0003
907 IRRITABLE BOWEL SYNDROME 7 0.0003
908 SKIN CANCER 7 0.0003
909 PROCEDURAL PAIN 9 0.0003
910 EMOTIONAL DISORDER 10 0.0003
911 DRY EYE 16 0.0003
912 CHRONIC KIDNEY DISEASE 24 0.0003
913 DISEASE RECURRENCE 15 0.0003
914 TACHYCARDIA 28 0.0003
915 TREMOR 52 0.0003
916 WEIGHT INCREASED 70 0.0003
917 HYPERHIDROSIS 40 0.0003
918 FEELING HOT 19 0.0003
919 RASH GENERALISED 8 0.0003
920 EAR PAIN 6 0.0003
921 SWELLING FACE 20 0.0003
922 NEPHROLITHIASIS 14 0.0003
923 SHOCK 7 0.0003
924 INFLUENZA LIKE ILLNESS 25 0.0003
925 ACTIVITIES OF DAILY LIVING IMPAIRED 6 0.0003
926 SINUS DISORDER 6 0.0003
927 ANXIETY 86 0.0003
928 CYTOMEGALOVIRUS INFECTION 5 0.0003
929 PRESCRIBED UNDERDOSE 6 0.0003
930 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 10 0.0003
931 PALPITATIONS 34 0.0003
932 THERAPY NON-RESPONDER 13 0.0003
933 ECZEMA 15 0.0003
934 EYE PAIN 16 0.0003
935 DIABETES MELLITUS INADEQUATE CONTROL 5 0.0003
936 PRURITUS GENERALISED 6 0.0003
937 PRODUCT DOSE OMISSION 18 0.0003
938 RASH MACULO-PAPULAR 6 0.0003
939 CONJUNCTIVITIS 5 0.0003
940 DEPRESSION 61 0.0003
941 NERVOUSNESS 14 0.0003
942 HOT FLUSH 20 0.0003
943 EAR INFECTION 7 0.0003
944 MIGRAINE 25 0.0003
945 URTICARIA 43 0.0003
946 NEUTROPENIA 34 0.0002
947 SINUSITIS 25 0.0002
948 BRONCHITIS 18 0.0002
949 INJURY 17 0.0002
950 LIP SWELLING 8 0.0002
951 RHEUMATOID ARTHRITIS 27 0.0002
952 OSTEOARTHRITIS 10 0.0002
953 DRUG RESISTANCE 6 0.0002
954 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 41 0.0002
955 FEAR 6 0.0002
956 IRRITABILITY 13 0.0002
957 PANCYTOPENIA 12 0.0002
958 FEBRILE NEUTROPENIA 14 0.0002
959 TREATMENT FAILURE 17 0.0002
960 GLYCOSYLATED HAEMOGLOBIN INCREASED 5 0.0002
961 DYSKINESIA 8 0.0002
962 ANAPHYLACTIC SHOCK 5 0.0002
963 EYE SWELLING 7 0.0002
964 TREATMENT NONCOMPLIANCE 10 0.0002
965 OSTEONECROSIS 6 0.0002
966 AGGRESSION 9 0.0002
967 ABNORMAL BEHAVIOUR 7 0.0002
968 UPPER RESPIRATORY TRACT INFECTION 8 0.0002
969 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
970 FLUSHING 17 0.0002
971 LEUKOPENIA 8 0.0002
972 PROSTATE CANCER 12 0.0001
973 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
974 PSORIASIS 19 0.0001
975 UNEVALUABLE EVENT 11 0.0001
976 DRUG DOSE OMISSION 24 0.0001
977 DRUG INEFFECTIVE 190 0.0001
978 AGITATION 10 0.0001
979 WHEEZING 8 0.0001
980 COLITIS ULCERATIVE 6 0.0001
981 ANGIOEDEMA 5 0.0001
982 MEDICATION ERROR 6 0.0001
983 ASTHMA 12 0.0001
984 EYE IRRITATION 6 0.0001
985 SUICIDAL IDEATION 9 0.0001
986 SKIN BURNING SENSATION 7 0.0001
987 ANAPHYLACTIC REACTION 5 0.0001
988 NO ADVERSE EVENT 15 0.0001
989 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 16 0.0001
990 BREAST CANCER 6 0.0001
991 INCORRECT DOSE ADMINISTERED 12 0.0001
992 OVERDOSE 10 0.0000